STOCK TITAN

CorVel Announces Revenues and Earnings

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

CorVel (NASDAQ: CRVL) reported fiscal year 2026 revenue of $959 million, up 7% from 2025, with EPS rising 17% to $2.14. Fourth-quarter revenue reached $249 million, up 7%, and EPS increased 20% to $0.61.

Q4 gross profit grew 9% to $63 million at a 25% margin. CorVel ended the quarter with $233 million in cash and no debt, and repurchased $20.1 million of stock. CERIS and P&C services saw strong demand, supported by investments in AI, automation, and telemedicine.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Fiscal 2026 revenue increased 7% to $959 million
  • Fiscal 2026 EPS rose 17% to $2.14
  • Q4 revenue up 7% to $249 million
  • Q4 EPS increased 20% to $0.61
  • Q4 gross profit grew 9% to $63 million with 25% margin
  • Ended quarter with $233 million cash and no borrowings
  • Repurchased $20.1 million of common stock in the quarter
  • Multiple large payer sales at CERIS increase revenue visibility

Negative

  • None.

Key Figures

FY26 Revenue: $959 million FY26 EPS: $2.14 Q4 Revenue: $249 million +5 more
8 metrics
FY26 Revenue $959 million Fiscal year ended March 31, 2026; up 7% from $896 million FY25
FY26 EPS $2.14 Fiscal year ended March 31, 2026; up 17% from $1.83 FY25
Q4 Revenue $249 million Quarter ended March 31, 2026; up from $232 million Q4 2025
Q4 EPS $0.61 Quarter ended March 31, 2026; up 20% vs $0.51 prior-year quarter
Q4 Gross Profit $63.0 million Fourth quarter FY26; 25% gross margin vs $58.0 million Q4 FY25
Cash & Equivalents $233 million Cash, cash equivalents, and no borrowings at quarter end
Share Repurchase $20.1 million Common stock repurchased during the quarter
Market Cap $3,023,620,551 Market capitalization prior to this earnings release

Market Reality Check

Price: $58.82 Vol: Volume 203,167 vs 20-day ...
normal vol
$58.82 Last Close
Volume Volume 203,167 vs 20-day avg 171,789 (relative volume 1.18). normal
Technical Price $58.82 trading below 200-day MA at $67.93, after a -0.49% prior-day move.

Peers on Argus

CRVL slipped -0.49% while key peers were mixed: several large brokers like AON s...
2 Up

CRVL slipped -0.49% while key peers were mixed: several large brokers like AON showed gains in momentum scans, but sector_context peers such as GSHD, BWIN, and WTW showed declines. Overall pattern points to stock-specific trading rather than a clear sector rotation.

Historical Context

5 past events · Latest: May 12 (Neutral)
Pattern 5 events
Date Event Sentiment Move Catalyst
May 12 Earnings webcast Neutral +1.2% Announcement of webcast to discuss upcoming earnings and outlook.
Apr 29 AI product launch Positive +0.3% Launch of CorVel Connected™, an AI-powered claims intelligence layer.
Feb 17 Workplace award Positive +0.6% Sixth consecutive Great Place To Work® Certification for innovation focus.
Feb 3 Earnings report Positive -26.1% Quarterly and nine‑month revenue and EPS growth with strong cash and buybacks.
Jan 20 Earnings webcast Neutral +1.0% Scheduled webcast to review quarterly results and strategic initiatives.
Pattern Detected

Most recent news (webcasts, AI launch, certification) saw modest positive price reactions, but the prior earnings release coincided with a sharp selloff, indicating occasionally adverse reactions to earnings despite growth metrics.

Recent Company History

Over the last six months, CRVL has highlighted technology and AI initiatives, employee-focused recognition, and regular earnings communication. AI-powered CorVel Connected™ launched on Apr 29, 2026 and drew a small positive move. Webcast announcements around earnings on Jan 20 and May 12 also saw mild gains. However, the Feb 3, 2026 earnings release, which reported revenue and EPS growth, was followed by a steep -26.05% move, contrasting with the generally constructive responses to other news items.

Market Pulse Summary

This announcement highlights steady growth, with fiscal year revenue of $959 million and EPS of $2.1...
Analysis

This announcement highlights steady growth, with fiscal year revenue of $959 million and EPS of $2.14, alongside quarterly EPS of $0.61 and gross profit of $63.0 million at a 25% margin. The company ended the period with $233 million in cash and no borrowings, and repurchased $20.1 million of stock. Recent history includes prior earnings volatility and continued investment in AI, automation, and telemedicine, so future updates on margins, cash deployment, and technology adoption remain key metrics to watch.

Key Terms

telemedicine, cybersecurity, AI
3 terms
telemedicine medical
"Ongoing investments in automation, telemedicine, cybersecurity, and API-driven connectivity..."
Telemedicine is the delivery of healthcare services remotely through digital communication tools, such as video calls or online messaging. It allows patients to consult with doctors and medical professionals without visiting a clinic in person. For investors, telemedicine represents a growing sector that combines technology and healthcare, potentially transforming how medical care is accessed and delivered worldwide.
cybersecurity technical
"Ongoing investments in automation, telemedicine, cybersecurity, and API-driven connectivity..."
Cybersecurity involves protecting computers, networks, and digital information from theft, damage, or unauthorized access. It is essential for safeguarding sensitive data and maintaining trust in digital systems, which matters to investors because strong cybersecurity reduces the risk of costly breaches and disruptions that can impact a company’s performance and reputation. Think of it as locking and safeguarding valuable information much like securing a safe to prevent theft.
AI technical
"supported by ongoing investment in AI and automation."
Artificial intelligence (AI) is technology that enables machines to mimic human thinking and learning, allowing them to analyze information, recognize patterns, and make decisions. For investors, AI matters because it can improve how businesses operate, create new products, or identify opportunities faster and more accurately than humans alone, potentially impacting company success and market trends.

AI-generated analysis. Not financial advice.

FORT WORTH, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $959 million, a 7% increase from $896 million during the fiscal year ended March 31, 2025. Earnings per share for the fiscal year ended March 31, 2026 were $2.14, up 17% compared to $1.83 during the fiscal year ended March 31, 2025. Revenues for the quarter were $249 million, an increase from $232 million in the March quarter of 2025. Earnings per share for the quarter were $0.61, up 20% compared to $0.51 in the same quarter of the prior year.

Fourth Quarter Fiscal Year 2026 Highlights 

  • Revenue increased 7% to $249 million, compared to fourth quarter of fiscal year 2025.
  • Gross profit increased 9% to $63.0 million, at 25% gross margin, compared to fourth quarter of fiscal year 2025 gross profit of $58.0 million.
  • Exited the quarter with $233 million of cash, cash equivalents, and no borrowings.
  • The Company repurchased $20.1 million of common stock during the quarter.

CERIS, CorVel’s health division, is benefiting from the healthcare industry’s shift toward proactive payment accuracy and cost management, with strong demand for its integrated prepay and post-pay platform that improves claims accuracy, reduces administrative burden, and enhances revenue visibility. During the quarter, multiple large payer sales with enterprise-scale implementations reflect the strength of the value proposition and provide increased revenue visibility as they are deployed and scaled over time. As adoption of prepay solutions expands, CERIS is accelerating revenue realization cycles while maintaining strong margin profiles, supported by ongoing investment in AI and automation.

Within workers’ compensation and risk management, P&C services are advancing its technology-enabled, clinically integrated model through the CorVel ConnectedTM interface within its proprietary CareMC platform. By combining AI, real-time data integration, and embedded clinical expertise, CorVel is improving decision-making support, operational efficiency, and claim outcomes across the lifecycle of a claim. Ongoing investments in automation, telemedicine, cybersecurity, and API-driven connectivity further strengthen scalability and the Company’s ability to deliver consistent clinical and financial results for its partners in environments where reliability, control, and measurable outcomes are critical.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, improved productivity resulting from automation and augmentation across enterprise business systems.  These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement results of operations and financial condition is greater than our initial assessment.  The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025, and the Company’s Quarterly Report on Form 10-Q for the quarters ended June 30, 2025, September 30, 2025, and December 31, 2025. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

CorVel Corporation
Quarterly Results – Income Statement
Quarters and Fiscal Year Ended March 31, 2026 and March 31, 2025

Quarter Ended March 31, 2026  March 31, 2025 
Revenues $248,548,000  $231,514,000 
Cost of revenues  185,539,000   173,547,000 
Gross profit  63,009,000   57,967,000 
General and administrative  23,293,000   24,647,000 
Income from operations  39,716,000   33,320,000 
Income tax provision  8,687,000   6,901,000 
Net income $31,029,000  $26,419,000 
Earnings Per Share:      
Basic $0.61  $0.51 
Diluted $0.61  $0.51 
Weighted Shares      
Basic  51,150,000   51,366,000 
Diluted  51,285,000   51,979,000 


Fiscal Year Ended March 31, 2026  March 31, 2025 
Revenues $958,527,000  $895,589,000 
Cost of revenues  725,664,000   685,861,000 
Gross profit  232,863,000   209,728,000 
General and administrative  89,732,000   88,904,000 
Income from operations  143,131,000   120,824,000 
Income tax provision  32,787,000   25,659,000 
Net income $110,344,000  $95,165,000 
Earnings Per Share:      
Basic $2.15  $1.85 
Diluted $2.14  $1.83 
Weighted Shares      
Basic  51,283,000   51,379,000 
Diluted  51,625,000   51,994,000 
         


CorVel Corporation
Quarterly Results – Condensed Balance Sheet
March 31, 2026 and March 31, 2025

  March 31, 2026  March 31, 2025 
Cash $233,072,000  $170,584,000 
Customer deposits  115,706,000   101,472,000 
Accounts receivable, net  101,313,000   104,126,000 
Prepaid taxes and expenses  12,206,000   10,507,000 
Property, net  117,906,000   92,052,000 
Goodwill and other assets  41,619,000   46,410,000 
Right-of-use asset, net  21,164,000   20,825,000 
Total $642,986,000  $545,976,000 
Accounts and taxes payable $24,550,000  $16,792,000 
Accrued liabilities  203,518,000   187,244,000 
Long-term lease liabilities  20,687,000   19,953,000 
Paid-in capital  268,518,000   250,412,000 
Treasury stock  (887,716,000)  (831,510,000)
Retained earnings  1,013,429,000   903,085,000 
Total $642,986,000  $545,976,000 
       

Contact: Melissa Storan
Phone: 949-851-1473
www.corvel.com


FAQ

How did CorVel (NASDAQ: CRVL) perform financially in fiscal year 2026?

CorVel reported fiscal 2026 revenue of $959 million, up 7%, and EPS of $2.14, up 17% year over year. According to CorVel, these gains reflect growth across its healthcare and workers’ compensation services, supported by technology and AI-driven solutions.

What were CorVel's Q4 2026 revenue and earnings per share (CRVL)?

CorVel posted fourth-quarter 2026 revenue of $249 million and EPS of $0.61. According to CorVel, revenue rose from $232 million and EPS from $0.51 in the prior-year quarter, with Q4 gross profit up 9% to $63 million at a 25% margin.

What is the significance of CorVel's cash position and share repurchases in Q4 2026?

CorVel ended Q4 2026 with $233 million in cash and no borrowings, and repurchased $20.1 million of stock. According to CorVel, this balance sheet strength and capital return reflect financial flexibility while continuing to invest in technology, AI, and automation initiatives.

How is CERIS contributing to CorVel's growth in fiscal 2026?

CERIS is benefiting from demand for proactive payment accuracy and cost management solutions. According to CorVel, multiple large payer sales and enterprise-scale implementations support increased revenue visibility, while adoption of prepay solutions accelerates revenue realization cycles and helps maintain strong margin profiles for the health division.

What technology investments is CorVel making in workers’ compensation and risk management?

CorVel is advancing its P&C services through the CorVel Connected interface within the CareMC platform. According to CorVel, combining AI, real-time data, and clinical expertise enhances decision support, efficiency, and claim outcomes, alongside investments in telemedicine, cybersecurity, automation, and API connectivity.

How did CorVel's gross profit and margins change in Q4 fiscal 2026?

CorVel's Q4 2026 gross profit increased 9% to $63 million, with a 25% gross margin. According to CorVel, this compares to $58 million gross profit in the prior-year quarter, indicating higher profitability alongside the 7% quarterly revenue growth to $249 million.